| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $461K | +50.0% |
| Cost of Revenue | $323K | +35.2% |
| Gross Profit | $138K | +101.8% |
| R&D Expense | $39K | -30.6% |
| SG&A Expense | $142K | +53.1% |
| Operating Income | -$568K | +25.5% |
| Interest Expense | $734K | +321.8% |
| Pre-tax Income | -$2.2M | -141.7% |
| Net Income | -$2.2M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34K | +625.1% |
| Accounts Receivable | $1K | -87.6% |
| Current Assets | $38K | +9.3% |
| Total Assets | $1.1M | +362.8% |
| Current Liabilities | $4.4M | +132.9% |
| Total Liabilities | $5.0M | +130.1% |
| Stockholders' Equity | -$4.0M | -102.6% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$424K | +4.7% |
| Investing Cash Flow | -$643K | -781.9% |
| Financing Cash Flow | $1.1M | +160.2% |
| -141.7% |